DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status-Post Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study

Information source: Alcon Research
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain Following Photorefractive Keratectomy (PRK)

Intervention: nepafenac (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Alcon Research

Official(s) and/or principal investigator(s):
Matthew Caldwell, Principal Investigator, Affiliation: Unaffiliated

Summary

Nepafenac 0. 1% or placebo (Balanced Salt Solution, BSS), 1 drop three times daily in contralateral eyes until healed.

To determine the comparable subjective pain level healing times of corneal epithelium (time to epithelial closure) after photorefractive keratectomy (PRK), while using either the commercial topical preparation of nepafenac (0. 1%) or placebo.

Clinical Details

Official title: A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status-Post Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study

Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment

Primary outcome: Patients were asked to rate the level of pain in each eye for the first three to five days after surgery.

Secondary outcome: Also, patients were examined daily for the first three to five days until corneal epithelial closure to evaluate the rate of epithelial healing.

Eligibility

Minimum age: 19 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 19 years or older with healthy ocular status and pre-operative refractive

anisometropia of less than 2. 000 diopters between eyes undergoing bilateral PRK surgery.

Exclusion Criteria:

- Those desiring PRK in only one eye, those in need of additional topical eye

medications, those with history of drug/alcohol abuse, women breastfeeding or pregnant.

Locations and Contacts

Lackland Air Force Base, San Antonio, Texas 78236, United States
Additional Information

Starting date: February 2006
Last updated: May 25, 2006

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008